-
2
-
-
0016433018
-
Plasma-high-density-lipoprotein concentration and development ofischaemic heart-disease
-
Miller, G.J., and Miller, N.E. 1975. Plasma-high-density-lipoprotein concentration and development ofischaemic heart-disease. Lancet. 1:16-19.
-
(1975)
Lancet
, vol.1
, pp. 16-19
-
-
Miller, G.J.1
Miller, N.E.2
-
3
-
-
0017384270
-
High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study
-
Gordon, T., Castelli, W.P., Hjortland, M.C., Kannet, W.B., and Dawber, T.R. 1977. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am. J. Med. 62:707-714.
-
(1977)
Am. J. Med.
, vol.62
, pp. 707-714
-
-
Gordon, T.1
Castelli, W.P.2
Hjortland, M.C.3
Kannet, W.B.4
Dawber, T.R.5
-
4
-
-
0018942421
-
Alpha-lipoprotein cholesterol concentration in relation to subsequent myocardial infarction in hypercholesterolemic men
-
Wiklund, O., er al. 1980. Alpha-lipoprotein cholesterol concentration in relation to subsequent myocardial infarction in hypercholesterolemic men. Atherosclerosis. 37:47-53.
-
(1980)
Atherosclerosis
, vol.37
, pp. 47-53
-
-
Wiklund, O.1
-
5
-
-
0023232216
-
Helsinki Heart Study: Primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease
-
Frick, M.H., et al. 1987. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl. J. Med. 317:1237-1245.
-
(1987)
N. Engl. J. Med.
, vol.317
, pp. 1237-1245
-
-
Frick, M.H.1
-
6
-
-
0024501678
-
High-density lipoprorein cholesterol and cardiovascular disease. Four prospective American studies
-
Gordon, D.J., et al. 1989. High-density lipoprorein cholesterol and cardiovascular disease. Four prospective American studies. Circulation. 79:8-15.
-
(1989)
Circulation
, vol.79
, pp. 8-15
-
-
Gordon, D.J.1
-
7
-
-
0028175551
-
Human HDL cholesterol levels are determined by apoA-I fractional catabolic rate, which correlates inversely with estimates of HDL particle size. Effects of gender, hepatic and lipoprorein lipases, triglyceride and insulin levels, and body fat distribution
-
Brinton, E.A., Eisenberg, S., and Breslow, J.L. 1994. Human HDL cholesterol levels are determined by apoA-I fractional catabolic rate, which correlates inversely with estimates of HDL particle size. Effects of gender, hepatic and lipoprorein lipases, triglyceride and insulin levels, and body fat distribution. Arterioscler. Thromb. 14:707-720.
-
(1994)
Arterioscler. Thromb.
, vol.14
, pp. 707-720
-
-
Brinton, E.A.1
Eisenberg, S.2
Breslow, J.L.3
-
8
-
-
0025104275
-
Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation
-
Inazu, A., et al. 1990. Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation. N. Engl. J. Med. 323:1234-1238.
-
(1990)
N. Engl. J. Med.
, vol.323
, pp. 1234-1238
-
-
Inazu, A.1
-
9
-
-
0030729724
-
A targeted mutation in the murine gene encoding the high density lipoprorein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism
-
Rigotti, A., et al. 1997. A targeted mutation in the murine gene encoding the high density lipoprorein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism. Proc. Natl. Acad. Sci. USA. 94:12610-12615.
-
(1997)
Proc. Natl. Acad. Sci. USA
, vol.94
, pp. 12610-12615
-
-
Rigotti, A.1
-
10
-
-
0027162816
-
Hepatic lipase deficiency. Clinical, biochemical, and molecular genetic characteristics
-
Hegele, R.A., et al. 1993. Hepatic lipase deficiency. Clinical, biochemical, and molecular genetic characteristics. Arterioscler. Thromb. 13:720-728.
-
(1993)
Arterioscler. Thromb.
, vol.13
, pp. 720-728
-
-
Hegele, R.A.1
-
11
-
-
0037314398
-
Endothelial lipase is a major determinant of HDL level
-
doi:10.1172/JCI200316306
-
Ishida, T., et al. 2003. Endothelial lipase is a major determinant of HDL level. J. Clin. Invest. 111:347-355. doi:10.1172/JCI200316306.
-
(2003)
J. Clin. Invest.
, vol.111
, pp. 347-355
-
-
Ishida, T.1
-
12
-
-
0037316555
-
Inhibition of endothelial lipase causes increased HDL cholesterol levels in vivo
-
doi: 10.1172/JCI200316146
-
Jin, W., Millar, J.S., Broedl, U., Glick, J.M., and Rader, D.J. 2003. Inhibition of endothelial lipase causes increased HDL cholesterol levels in vivo. J. Clin. Invest. 111:357-362. doi: 10.1172/JCI200316146.
-
(2003)
J. Clin. Invest.
, vol.111
, pp. 357-362
-
-
Jin, W.1
Millar, J.S.2
Broedl, U.3
Glick, J.M.4
Rader, D.J.5
-
13
-
-
0033553565
-
Cloning of a unique lipase from endothelial cells extends the lipase gene family
-
Hirata, K., et al. 1999. Cloning of a unique lipase from endothelial cells extends the lipase gene family. J. Biol. Chem. 274:14170-14175.
-
(1999)
J. Biol. Chem.
, vol.274
, pp. 14170-14175
-
-
Hirata, K.1
-
14
-
-
0032901331
-
A novel endothelial-derived lipase that modulates HDL metabolism
-
Jaye, M., et al. 1999. A novel endothelial-derived lipase that modulates HDL metabolism. Nat. Genet. 21:424-428.
-
(1999)
Nat. Genet.
, vol.21
, pp. 424-428
-
-
Jaye, M.1
-
15
-
-
0035988350
-
Characterization of the lipolytic activity of endothelial lipase
-
McCoy, M.G., et al. 2002. Characterization of the lipolytic activity of endothelial lipase. J. Lipid. Res. 43:921-929.
-
(2002)
J. Lipid. Res.
, vol.43
, pp. 921-929
-
-
McCoy, M.G.1
-
17
-
-
0037056085
-
Identification of genetic variants in endothelial lipase in persons with elevated high-density lipoprotein cholesterol
-
deLemos, A.S., Wolfe, M.L., Long, C.J., Sivapackianathan, R, and Rader, D.J. 2002. Identification of genetic variants in endothelial lipase in persons with elevated high-density lipoprotein cholesterol. Circulation. 106:1321-1326.
-
(2002)
Circulation
, vol.106
, pp. 1321-1326
-
-
DeLemos, A.S.1
Wolfe, M.L.2
Long, C.J.3
Sivapackianathan, R.4
Rader, D.J.5
|